Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Oral LPCN 1154A in Women With Postpartum Depression

NCT07822321 is registered in ClinicalTrials.gov with Lipocine Inc. as lead sponsor.

NCT NCT07822321
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07822321 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Oral LPCN 1154A in Women With Postpartum Depression
Lead sponsor
Lipocine Inc.
Phase
Phase 3
Overall status
Recruiting
Start date
September 30, 2026
Completion date
September 30, 2027
Enrollment
120 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

depression, postpartum, peripartum depression, post-natal depression, post-partum depression, postnatal depression, postpartum depression (ppd)